Title |
Effect of Maintenance Tocolysis With Nifedipine in Threatened Preterm Labor on Perinatal Outcomes: A Randomized Controlled Trial
|
---|---|
Published in |
JAMA: Journal of the American Medical Association, January 2013
|
DOI | 10.1001/jama.2012.153817 |
Pubmed ID | |
Authors |
Carolien Roos, Marc E. A. Spaanderman, Ewoud Schuit, Kitty W. M. Bloemenkamp, Antoinette C. Bolte, Jérôme Cornette, Johannes J. J. Duvekot, Jim van Eyck, Maureen T. M. Franssen, Christianne J. de Groot, Joke H. Kok, Anneke Kwee, Ashley Merién, Bas Nij Bijvank, Brent C. Opmeer, Martijn A. Oudijk, Mariëlle G. van Pampus, Dimitri N. M. Papatsonis, Martina M. Porath, Hubertina C. J. Scheepers, Sicco A. Scherjon, Krystyna M. Sollie, Sylvia M. C. Vijgen, Christine Willekes, Ben Willem J. Mol, Joris A. M. van der Post, Fred K. Lotgering, for the APOSTEL-II Study Group |
Abstract |
In threatened preterm labor, maintenance tocolysis with nifedipine, after an initial course of tocolysis and corticosteroids for 48 hours, may improve perinatal outcome. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 17% |
United States | 1 | 17% |
Japan | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 67% |
Scientists | 1 | 17% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 1% |
Spain | 1 | <1% |
Netherlands | 1 | <1% |
United States | 1 | <1% |
Unknown | 129 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 21 | 16% |
Student > Master | 16 | 12% |
Student > Ph. D. Student | 15 | 11% |
Student > Bachelor | 13 | 10% |
Student > Postgraduate | 12 | 9% |
Other | 33 | 25% |
Unknown | 24 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 76 | 57% |
Nursing and Health Professions | 12 | 9% |
Psychology | 4 | 3% |
Agricultural and Biological Sciences | 3 | 2% |
Immunology and Microbiology | 3 | 2% |
Other | 7 | 5% |
Unknown | 29 | 22% |